• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Asthma Devices Market Share

    ID: MRFR/MED/1093-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Asthma Device Market Research Report Information By Type (Inhalers, Nebulizers, Dry Powder Inhalers, Metered-Dose Inhalers, Mesh Nebulizers) By Technology (Manually Operated, Digitally Operated) By End Users (Hospital, Retail Pharmacies)-Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asthma Devices Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Asthma Devices Market Share Analysis

    The asthma treatment and control market is competitive. As lung healthcare evolves swiftly, corporations utilize a number of strategic placement tactics to maintain and expand market share. New puffer technologies are being heavily funded by asthma medication companies. This comprises smart inhalers, breath-activated inhalers, and dose-measuring devices. Businesses may attract physicians and asthmatics seeking better asthma treatment by leveraging modern technology. Successful companies recognize how crucial patient satisfaction is, therefore they design their breathing devices with patients in mind. This includes creating easy-to-use, portable, and attractive devices. Focusing on patient comfort and simplicity makes goods more popular and positions firms as leaders in easy-to-use asthma management treatments. Businesses frequently position themselves as illness management experts in addition to selling technology. This comprises all-in-one systems with breathing technology, smartphone applications for symptom tracking, and internet connection for remote monitoring. Providing an asthma management environment boosts a company's market position. Breathing product companies should expand globally. Changing items to fit varied norms and regional healthcare demands is required. When firms expand worldwide, they gain clients and become global asthma control leaders. Companies invest money on educating and training because they know asthma equipment must be used appropriately. These programs educate healthcare personnel and patients how to use inhalers, conduct inhalations, and follow treatment regimens. Focusing on education improves performance and business image. Gaining market share requires collaboration with healthcare firms. Companies partner with hospitals, clinics, and medical professionals to promote their breathing products. These partnerships make it simpler to collect product input, which improves them, and promote healthcare reputation. Manufacturers of breathing products must follow tight regulations. To ensure product safety and efficacy, companies prioritize regulator compliance. Quality assurance boosts healthcare workers' confidence and the company's market image. Because lung healthcare changes, goods must continuously be improved. Companies invest in R&D to improve breathing products' reliability, functionality, and features. Technologically advanced companies lead their industries. Making breathing devices inexpensive and accessible is crucial to market share positioning. Companies that increase product quality, negotiate better costs, and explore financial assistance schemes make their goods more accessible. This technique benefits healthcare personnel and consumers, increasing market share.

    Market Summary

    The Global Asthma Devices Market is projected to grow from 4.21 USD Billion in 2024 to 8.6 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Global Asthma Devices Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 6.71% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 8.6 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 4.21 USD Billion, laying a solid foundation for future expansion.
    • Growing adoption of advanced inhalation technologies due to increasing prevalence of asthma is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.21 (USD Billion)
    2035 Market Size 8.6 (USD Billion)
    CAGR (2025-2035) 6.71%
    Largest Regional Market Share in 2024 south_america)

    Major Players

    GlaxoSmithKline plc., Merck & Co., Inc., 3M, Aristopharma Ltd., SRS PHARMACEUTICALS PVT. LTD., AstraZeneca, Baxter, Boehringer Ingelheim GmbH, Koninklijke Philips N.V.

    Market Trends

    The increasing prevalence of asthma globally, coupled with advancements in device technology, suggests a robust growth trajectory for the asthma devices market, driven by the need for effective management solutions.

    World Health Organization (WHO)

    Asthma Devices Market Market Drivers

    Rising Prevalence of Asthma

    The increasing prevalence of asthma globally serves as a primary driver for the Global Global Asthma Devices Market Industry. According to health statistics, asthma affects approximately 300 million individuals worldwide, with numbers expected to rise. This growing patient population necessitates the development and distribution of effective asthma management devices. The market is projected to reach 4.21 USD Billion in 2024, reflecting the urgent need for innovative solutions. As awareness of asthma management improves, the demand for devices such as inhalers and nebulizers is likely to increase, further propelling market growth.

    Market Segment Insights

    On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.

    Asthma Devices Technology Insights

      On the basis of technology, the asthma devices market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.

    Asthma Devices End-User Insights

      On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.

    Get more detailed insights about Asthma Devices Market Research Report – Forecast till 2032

    Regional Insights

    Key Companies in the Asthma Devices Market market include

    Industry Developments

    Future Outlook

    Asthma Devices Market Future Outlook

    The Global Asthma Devices Market is projected to grow at a 6.71% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of asthma, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop smart inhalers with integrated digital health solutions for real-time monitoring.
    • Expand product lines to include eco-friendly, sustainable asthma devices.
    • Leverage telemedicine platforms to enhance patient engagement and adherence to treatment.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in asthma management technologies.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023 4 (USD Billion)
    Market Size 2024 4.21 (USD Billion)
    Market Size 2032 7.45 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.89 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others
      Key Market Opportunities   The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases
      Key Market Drivers   Increasing prevalence of asthma

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. TABLE OF CONTENT
    2. Chapter 1. Report Prologue
    3. Chapter 2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary research
      4. Market Size Estimation
    5. Chapter 4. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    6. Chapter 5. Market Factor Analysis
      1. Porters Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Chapter 6. Global Asthma Devices Market, by Type
      1. Introduction
      2. Inhalers
    8. Market Estimates & Forecast, 2020-2027
      1. Metered-Dose Inhalers
        1. Standard Pressurized Metered-Dose Inhalers
        2. Dry Powder Inhalers
        3. Others
      2. Nebulizers Market Estimates & Forecast, 2020-2027
        1. Compressor Nebulizers
        2. Ultrasonic Nebulizers
        3. Mesh Nebulizers
        4. Others
      3. Others
    9. Chapter 7. Global Asthma Devices Market, by Technology
      1. Introduction
      2. Manually Operated Inhaler Devices Market Estimates & Forecast, 2020-2027
      3. Digitally Operated Inhaler Devices Market Estimates & Forecast, 2020-2027
      4. Others
    10. Chapter 8. Global Asthma Devices Market, by End Users
      1. Introduction
      2. Hospitals & Clinics Market Estimates & Forecast, 2020-2027
      3. Retail Pharmacies Market Estimates & Forecast, 2020-2027
      4. Home Care Market Estimates & Forecast, 2020-2027
      5. Others
    11. Chapter 9. Global Asthma Devices Market, by Region
      1. Introduction
      2. America
        1. North America
        2. South America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic of Korea
        6. Rest of Asia Pacific
      5. The Middle East & Africa
        1. United Arab Emirates
        2. Saudi Arabia
        3. Oman
        4. Kuwait
        5. Qatar
        6. Rest of the Middle East & Africa
    12. Chapter 10. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    13. Chapter 11 Company Profiles
      1. GlaxoSmithKline plc.
        1. Company Overview
        2. Type Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      2. Merck & Co., Inc.
        1. Company Overview
        2. Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. 3M
        1. Company Overview
        2. Type Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Aristopharma Ltd.
        1. Company Overview
        2. Type/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. SRS PHARMACEUTICALS PVT. LTD.
        1. Company Overview
        2. Type Overview
        3. Financial overview
        4. Key Developments
        5. SWOT Analysis
      6. AstraZeneca
        1. Company Overview
        2. Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      7. Baxter
        1. Overview
        2. Type Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Boehringer Ingelheim GmbH
        1. Overview
        2. Type Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Koninklijke Philips N.V.
        1. Overview
        2. Type Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      10. Others
    14. Chapter 12 MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Prediction of Global Asthma Devices Market
    15. Chapter 13 Appendix
    16. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Global Asthma Devices Industry Synopsis, 2020-2027
      3. Table 2 Global Asthma Devices Market Estimates and Forecast, 2020-2027, (USD Million)
      4. Table 3 Global Asthma Devices Market by Region, 2020-2027, (USD Million)
      5. Table 4 Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      6. Table 5 Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      7. Table 6 Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      8. Table 7 North America Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      9. Table 8 North America Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      10. Table 9 North America Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      11. Table 10 U.S. Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      12. Table 11 U.S. Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      13. Table 12 U.S. Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      14. Table 13 Canada Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      15. Table 14 Canada Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      16. Table 15 Canada Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      17. Table 16 South America Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      18. Table 17 South America Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      19. Table 18 South America Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      20. Table 19 Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      21. Table 20 Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      22. Table 21 Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      23. Table 22 Western Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      24. Table 23 Western Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      25. Table 24 Western Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      26. Table 25 Eastern Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      27. Table 26 Eastern Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      28. Table 27 Eastern Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      29. Table 28 Asia Pacific Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      30. Table 29 Asia Pacific Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      31. Table 30 Asia Pacific Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
      32. Table 31 Middle East & Africa Global Asthma Devices Market by Type, 2020-2027, (USD Million)
      33. Table 32 Middle East & Africa Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
      34. Table 33 Middle East & Africa Global Asthma Devices Market by End Users, 2020-2027, (USD Million) LIST OF FIGURES
      35. Figure 1 Research Process
      36. Figure 2 Segmentation for Global Asthma Devices Market
      37. Figure 3 Market Dynamics for Global Asthma Devices Market
      38. Figure 4 Global Asthma Devices Market Share, by Type 2020
      39. Figure 5 Global Asthma Devices Market Share, by Technology 2020
      40. Figure 6 Global Asthma Devices Market Share, by End Users, 2020
      41. Figure 7 Global Asthma Devices Market Share, by Region, 2020
      42. Figure 8 North America Global Asthma Devices Market Share, by Country, 2020
      43. Figure 9 Europe Global Asthma Devices Market Share, by Country, 2020
      44. Figure 10 Asia Pacific Global Asthma Devices Market Share, by Country, 2020
      45. Figure 11 Middle East & Africa Global Asthma Devices Market Share, by Country, 2020
      46. Figure 12 Global Asthma Devices Market: Company Share Analysis, 2020 (%)
      47. Figure 13 GlaxoSmithKline plc.: Key Financials
      48. Figure 14 GlaxoSmithKline plc.: Segmental Revenue
      49. Figure 15 GlaxoSmithKline plc.: Geographical Revenue
      50. Figure 16 Merck & Co., Inc.: Type UK Ltd: Key Financials
      51. Figure 17 Merck & Co., Inc.: Type UK Ltd: Segmental Revenue
      52. Figure 18 Merck & Co., Inc.: Type UK Ltd: Geographical Revenue
      53. Figure 19 3M: Key Financials
      54. Figure 20 3M: Segmental Revenue
      55. Figure 21 3M: Geographical Revenue
      56. Figure 22 Aristopharma Ltd.: Key Financials
      57. Figure 23 Aristopharma Ltd.: Segmental Revenue
      58. Figure 24 Aristopharma Ltd.: Geographical Revenue
      59. Figure 25 SRS PHARMACEUTICALS PVT. LTD.: Key Financials
      60. Figure 26 SRS PHARMACEUTICALS PVT. LTD.: Segmental Revenue
      61. Figure 27 SRS PHARMACEUTICALS PVT. LTD.: Geographical Revenue
      62. Figure 28 AstraZeneca: Key Financials
      63. Figure 29 AstraZeneca: Segmental Revenue
      64. Figure 30 AstraZeneca: Geographical Revenue
      65. Figure 31 Baxter.: Key Financials
      66. Figure 32 Baxter.: Segmental Revenue
      67. Figure 33 Baxter.: Geographical Revenue
      68. Figure 34 Boehringer Ingelheim GmbH: Key Financials
      69. Figure 35 Boehringer Ingelheim GmbH: Segmental Revenue
      70. Figure 36 Boehringer Ingelheim GmbH: Geographical Revenue
      71. Figure 37 Koninklijke Philips N.V.: Key Financials
      72. Figure 38 Koninklijke Philips N.V.: Segmental Revenue
      73. Figure 39 Koninklijke Philips N.V.: Geographical Revenue

    Asthma Devices Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials